nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—TPMT—nipple—breast cancer	0.00982	0.0623	CbGeAlD
Bendroflumethiazide—SLC12A3—female reproductive system—breast cancer	0.00661	0.0419	CbGeAlD
Bendroflumethiazide—KCNMA1—epithelium—breast cancer	0.00615	0.039	CbGeAlD
Bendroflumethiazide—TPMT—endometrium—breast cancer	0.00593	0.0376	CbGeAlD
Bendroflumethiazide—CA4—nipple—breast cancer	0.00542	0.0344	CbGeAlD
Bendroflumethiazide—TPMT—pituitary gland—breast cancer	0.00536	0.034	CbGeAlD
Bendroflumethiazide—TPMT—adipose tissue—breast cancer	0.00534	0.0339	CbGeAlD
Bendroflumethiazide—KCNMA1—uterus—breast cancer	0.00508	0.0322	CbGeAlD
Bendroflumethiazide—KCNMA1—adipose tissue—breast cancer	0.00497	0.0315	CbGeAlD
Bendroflumethiazide—TPMT—adrenal gland—breast cancer	0.00479	0.0304	CbGeAlD
Bendroflumethiazide—TPMT—bone marrow—breast cancer	0.00464	0.0294	CbGeAlD
Bendroflumethiazide—KCNMA1—female reproductive system—breast cancer	0.00457	0.029	CbGeAlD
Bendroflumethiazide—CA2—nipple—breast cancer	0.0045	0.0285	CbGeAlD
Bendroflumethiazide—TPMT—female gonad—breast cancer	0.00447	0.0283	CbGeAlD
Bendroflumethiazide—KCNMA1—adrenal gland—breast cancer	0.00446	0.0283	CbGeAlD
Bendroflumethiazide—TPMT—endocrine gland—breast cancer	0.00415	0.0263	CbGeAlD
Bendroflumethiazide—KCNMA1—endocrine gland—breast cancer	0.00387	0.0245	CbGeAlD
Bendroflumethiazide—CA1—adipose tissue—breast cancer	0.00378	0.0239	CbGeAlD
Bendroflumethiazide—Benzthiazide—CA9—breast cancer	0.00374	0.296	CrCbGaD
Bendroflumethiazide—CA2—embryo—breast cancer	0.00371	0.0235	CbGeAlD
Bendroflumethiazide—CA1—female reproductive system—breast cancer	0.00347	0.022	CbGeAlD
Bendroflumethiazide—CA1—bone marrow—breast cancer	0.00328	0.0208	CbGeAlD
Bendroflumethiazide—Hydroflumethiazide—CA9—breast cancer	0.00313	0.248	CrCbGaD
Bendroflumethiazide—Hydrochlorothiazide—CA9—breast cancer	0.00305	0.241	CrCbGaD
Bendroflumethiazide—CA2—epithelium—breast cancer	0.00303	0.0192	CbGeAlD
Bendroflumethiazide—CA4—pituitary gland—breast cancer	0.00296	0.0188	CbGeAlD
Bendroflumethiazide—CA4—adipose tissue—breast cancer	0.00295	0.0187	CbGeAlD
Bendroflumethiazide—CA1—endocrine gland—breast cancer	0.00294	0.0186	CbGeAlD
Bendroflumethiazide—CA2—skin of body—breast cancer	0.00288	0.0183	CbGeAlD
Bendroflumethiazide—TPMT—lymph node—breast cancer	0.00287	0.0182	CbGeAlD
Bendroflumethiazide—Trichlormethiazide—CA9—breast cancer	0.00271	0.215	CrCbGaD
Bendroflumethiazide—CA4—female reproductive system—breast cancer	0.00271	0.0172	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—breast cancer	0.00267	0.0169	CbGeAlD
Bendroflumethiazide—CA4—adrenal gland—breast cancer	0.00265	0.0168	CbGeAlD
Bendroflumethiazide—CA4—bone marrow—breast cancer	0.00256	0.0162	CbGeAlD
Bendroflumethiazide—CA4—female gonad—breast cancer	0.00247	0.0157	CbGeAlD
Bendroflumethiazide—CA2—pituitary gland—breast cancer	0.00246	0.0156	CbGeAlD
Bendroflumethiazide—CA2—adipose tissue—breast cancer	0.00245	0.0155	CbGeAlD
Bendroflumethiazide—CA4—endocrine gland—breast cancer	0.0023	0.0146	CbGeAlD
Bendroflumethiazide—CA2—female reproductive system—breast cancer	0.00225	0.0143	CbGeAlD
Bendroflumethiazide—CA2—adrenal gland—breast cancer	0.00219	0.0139	CbGeAlD
Bendroflumethiazide—CA2—bone marrow—breast cancer	0.00212	0.0135	CbGeAlD
Bendroflumethiazide—CA2—female gonad—breast cancer	0.00205	0.013	CbGeAlD
Bendroflumethiazide—CA1—lymph node—breast cancer	0.00203	0.0129	CbGeAlD
Bendroflumethiazide—CA2—endocrine gland—breast cancer	0.0019	0.0121	CbGeAlD
Bendroflumethiazide—CA4—lymph node—breast cancer	0.00159	0.0101	CbGeAlD
Bendroflumethiazide—Asthenia—Letrozole—breast cancer	0.00136	0.00323	CcSEcCtD
Bendroflumethiazide—Asthenia—Anastrozole—breast cancer	0.00136	0.00323	CcSEcCtD
Bendroflumethiazide—Vomiting—Exemestane—breast cancer	0.00136	0.00322	CcSEcCtD
Bendroflumethiazide—Rash—Exemestane—breast cancer	0.00134	0.00319	CcSEcCtD
Bendroflumethiazide—Dermatitis—Exemestane—breast cancer	0.00134	0.00319	CcSEcCtD
Bendroflumethiazide—Dizziness—Ixabepilone—breast cancer	0.00133	0.00316	CcSEcCtD
Bendroflumethiazide—Blood disorder—Doxorubicin—breast cancer	0.00132	0.00314	CcSEcCtD
Bendroflumethiazide—CA2—lymph node—breast cancer	0.00132	0.00834	CbGeAlD
Bendroflumethiazide—Thirst—Capecitabine—breast cancer	0.00131	0.00311	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Vinblastine—breast cancer	0.00131	0.0031	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Anastrozole—breast cancer	0.0013	0.00308	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Letrozole—breast cancer	0.0013	0.00308	CcSEcCtD
Bendroflumethiazide—Purpura—Capecitabine—breast cancer	0.00129	0.00307	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Paclitaxel—breast cancer	0.00129	0.00305	CcSEcCtD
Bendroflumethiazide—Vomiting—Ixabepilone—breast cancer	0.00128	0.00304	CcSEcCtD
Bendroflumethiazide—Anorexia—Vinblastine—breast cancer	0.00127	0.00302	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Tamoxifen—breast cancer	0.00127	0.00301	CcSEcCtD
Bendroflumethiazide—Rash—Ixabepilone—breast cancer	0.00127	0.00301	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ixabepilone—breast cancer	0.00127	0.00301	CcSEcCtD
Bendroflumethiazide—Nausea—Exemestane—breast cancer	0.00127	0.003	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Chlorambucil—breast cancer	0.00127	0.003	CcSEcCtD
Bendroflumethiazide—Dizziness—Anastrozole—breast cancer	0.00125	0.00297	CcSEcCtD
Bendroflumethiazide—Dizziness—Letrozole—breast cancer	0.00125	0.00297	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Melphalan—breast cancer	0.00124	0.00295	CcSEcCtD
Bendroflumethiazide—Anorexia—Tamoxifen—breast cancer	0.00124	0.00293	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Idarubicin—breast cancer	0.00123	0.00292	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Raloxifene—breast cancer	0.00123	0.00292	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Goserelin—breast cancer	0.00121	0.00288	CcSEcCtD
Bendroflumethiazide—Anorexia—Melphalan—breast cancer	0.00121	0.00287	CcSEcCtD
Bendroflumethiazide—Vomiting—Anastrozole—breast cancer	0.0012	0.00286	CcSEcCtD
Bendroflumethiazide—Vomiting—Letrozole—breast cancer	0.0012	0.00286	CcSEcCtD
Bendroflumethiazide—Nausea—Ixabepilone—breast cancer	0.0012	0.00284	CcSEcCtD
Bendroflumethiazide—Rash—Anastrozole—breast cancer	0.00119	0.00283	CcSEcCtD
Bendroflumethiazide—Rash—Letrozole—breast cancer	0.00119	0.00283	CcSEcCtD
Bendroflumethiazide—Dermatitis—Anastrozole—breast cancer	0.00119	0.00283	CcSEcCtD
Bendroflumethiazide—Dermatitis—Letrozole—breast cancer	0.00119	0.00283	CcSEcCtD
Bendroflumethiazide—Dizziness—Raloxifene—breast cancer	0.00119	0.00282	CcSEcCtD
Bendroflumethiazide—Hypotension—Melphalan—breast cancer	0.00119	0.00281	CcSEcCtD
Bendroflumethiazide—Anorexia—Goserelin—breast cancer	0.00118	0.0028	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Docetaxel—breast cancer	0.00118	0.00279	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Vinblastine—breast cancer	0.00116	0.00275	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Docetaxel—breast cancer	0.00116	0.00275	CcSEcCtD
Bendroflumethiazide—Hypotension—Goserelin—breast cancer	0.00116	0.00275	CcSEcCtD
Bendroflumethiazide—Urine output increased—Methotrexate—breast cancer	0.00116	0.00274	CcSEcCtD
Bendroflumethiazide—Vomiting—Raloxifene—breast cancer	0.00114	0.00271	CcSEcCtD
Bendroflumethiazide—Vomiting—Idarubicin—breast cancer	0.00114	0.00271	CcSEcCtD
Bendroflumethiazide—Constipation—Vinblastine—breast cancer	0.00114	0.00271	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Capecitabine—breast cancer	0.00114	0.0027	CcSEcCtD
Bendroflumethiazide—Rash—Raloxifene—breast cancer	0.00113	0.00269	CcSEcCtD
Bendroflumethiazide—Rash—Idarubicin—breast cancer	0.00113	0.00269	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Capecitabine—breast cancer	0.00113	0.00269	CcSEcCtD
Bendroflumethiazide—Dermatitis—Idarubicin—breast cancer	0.00113	0.00269	CcSEcCtD
Bendroflumethiazide—Dermatitis—Raloxifene—breast cancer	0.00113	0.00269	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Tamoxifen—breast cancer	0.00113	0.00267	CcSEcCtD
Bendroflumethiazide—Nausea—Anastrozole—breast cancer	0.00113	0.00267	CcSEcCtD
Bendroflumethiazide—Nausea—Letrozole—breast cancer	0.00113	0.00267	CcSEcCtD
Bendroflumethiazide—Constipation—Tamoxifen—breast cancer	0.00111	0.00263	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Melphalan—breast cancer	0.0011	0.00262	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Vinorelbine—breast cancer	0.00109	0.00258	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Irinotecan—breast cancer	0.00108	0.00256	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Goserelin—breast cancer	0.00108	0.00255	CcSEcCtD
Bendroflumethiazide—Nausea—Idarubicin—breast cancer	0.00107	0.00253	CcSEcCtD
Bendroflumethiazide—Nausea—Raloxifene—breast cancer	0.00107	0.00253	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Methotrexate—breast cancer	0.00107	0.00253	CcSEcCtD
Bendroflumethiazide—Constipation—Goserelin—breast cancer	0.00106	0.00251	CcSEcCtD
Bendroflumethiazide—Anorexia—Vinorelbine—breast cancer	0.00106	0.00251	CcSEcCtD
Bendroflumethiazide—Polyuria—Methotrexate—breast cancer	0.00106	0.00251	CcSEcCtD
Bendroflumethiazide—Asthenia—Chlorambucil—breast cancer	0.00105	0.00248	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Thiotepa—breast cancer	0.00104	0.00246	CcSEcCtD
Bendroflumethiazide—Hypotension—Vinorelbine—breast cancer	0.00104	0.00246	CcSEcCtD
Bendroflumethiazide—Anorexia—Thiotepa—breast cancer	0.00101	0.0024	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Epirubicin—breast cancer	0.000998	0.00237	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Chlorambucil—breast cancer	0.000997	0.00236	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Epirubicin—breast cancer	0.00097	0.0023	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Vinorelbine—breast cancer	0.000964	0.00229	CcSEcCtD
Bendroflumethiazide—Asthenia—Vinblastine—breast cancer	0.000958	0.00227	CcSEcCtD
Bendroflumethiazide—Constipation—Vinorelbine—breast cancer	0.000949	0.00225	CcSEcCtD
Bendroflumethiazide—Asthenia—Tamoxifen—breast cancer	0.00093	0.00221	CcSEcCtD
Bendroflumethiazide—Vomiting—Chlorambucil—breast cancer	0.000926	0.0022	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—breast cancer	0.000923	0.00219	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Thiotepa—breast cancer	0.000921	0.00218	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vinblastine—breast cancer	0.000913	0.00217	CcSEcCtD
Bendroflumethiazide—Asthenia—Melphalan—breast cancer	0.000911	0.00216	CcSEcCtD
Bendroflumethiazide—Constipation—Thiotepa—breast cancer	0.000906	0.00215	CcSEcCtD
Bendroflumethiazide—Purpura—Epirubicin—breast cancer	0.000901	0.00214	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—breast cancer	0.000898	0.00213	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Mitoxantrone—breast cancer	0.000896	0.00212	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Irinotecan—breast cancer	0.000896	0.00212	CcSEcCtD
Bendroflumethiazide—Asthenia—Goserelin—breast cancer	0.000889	0.00211	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Tamoxifen—breast cancer	0.000887	0.0021	CcSEcCtD
Bendroflumethiazide—Dizziness—Vinblastine—breast cancer	0.000883	0.00209	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Paclitaxel—breast cancer	0.000879	0.00209	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gemcitabine—breast cancer	0.000873	0.00207	CcSEcCtD
Bendroflumethiazide—Anorexia—Irinotecan—breast cancer	0.000872	0.00207	CcSEcCtD
Bendroflumethiazide—Anorexia—Mitoxantrone—breast cancer	0.000872	0.00207	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Melphalan—breast cancer	0.000869	0.00206	CcSEcCtD
Bendroflumethiazide—Nausea—Chlorambucil—breast cancer	0.000865	0.00205	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Fluorouracil—breast cancer	0.000858	0.00204	CcSEcCtD
Bendroflumethiazide—Dizziness—Tamoxifen—breast cancer	0.000858	0.00203	CcSEcCtD
Bendroflumethiazide—Hypotension—Mitoxantrone—breast cancer	0.000855	0.00203	CcSEcCtD
Bendroflumethiazide—Hypotension—Irinotecan—breast cancer	0.000855	0.00203	CcSEcCtD
Bendroflumethiazide—Anorexia—Gemcitabine—breast cancer	0.00085	0.00202	CcSEcCtD
Bendroflumethiazide—Vomiting—Vinblastine—breast cancer	0.000849	0.00201	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Goserelin—breast cancer	0.000847	0.00201	CcSEcCtD
Bendroflumethiazide—Anorexia—Fluorouracil—breast cancer	0.000835	0.00198	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—breast cancer	0.000833	0.00198	CcSEcCtD
Bendroflumethiazide—Hypotension—Gemcitabine—breast cancer	0.000833	0.00198	CcSEcCtD
Bendroflumethiazide—Vomiting—Tamoxifen—breast cancer	0.000825	0.00196	CcSEcCtD
Bendroflumethiazide—Dizziness—Goserelin—breast cancer	0.000819	0.00194	CcSEcCtD
Bendroflumethiazide—Hypotension—Fluorouracil—breast cancer	0.000819	0.00194	CcSEcCtD
Bendroflumethiazide—Rash—Tamoxifen—breast cancer	0.000818	0.00194	CcSEcCtD
Bendroflumethiazide—Dermatitis—Tamoxifen—breast cancer	0.000817	0.00194	CcSEcCtD
Bendroflumethiazide—Vomiting—Melphalan—breast cancer	0.000807	0.00192	CcSEcCtD
Bendroflumethiazide—Rash—Melphalan—breast cancer	0.000801	0.0019	CcSEcCtD
Bendroflumethiazide—Dermatitis—Melphalan—breast cancer	0.0008	0.0019	CcSEcCtD
Bendroflumethiazide—Asthenia—Vinorelbine—breast cancer	0.000796	0.00189	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Mitoxantrone—breast cancer	0.000795	0.00189	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Irinotecan—breast cancer	0.000795	0.00189	CcSEcCtD
Bendroflumethiazide—Nausea—Vinblastine—breast cancer	0.000793	0.00188	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—breast cancer	0.000793	0.00188	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—breast cancer	0.00079	0.00187	CcSEcCtD
Bendroflumethiazide—Vomiting—Goserelin—breast cancer	0.000788	0.00187	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Methotrexate—breast cancer	0.000786	0.00186	CcSEcCtD
Bendroflumethiazide—Constipation—Irinotecan—breast cancer	0.000782	0.00186	CcSEcCtD
Bendroflumethiazide—Constipation—Mitoxantrone—breast cancer	0.000782	0.00186	CcSEcCtD
Bendroflumethiazide—Rash—Goserelin—breast cancer	0.000781	0.00185	CcSEcCtD
Bendroflumethiazide—Dermatitis—Goserelin—breast cancer	0.00078	0.00185	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gemcitabine—breast cancer	0.000775	0.00184	CcSEcCtD
Bendroflumethiazide—Nausea—Tamoxifen—breast cancer	0.00077	0.00183	CcSEcCtD
Bendroflumethiazide—Constipation—Gemcitabine—breast cancer	0.000762	0.00181	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Fluorouracil—breast cancer	0.000762	0.00181	CcSEcCtD
Bendroflumethiazide—Asthenia—Thiotepa—breast cancer	0.00076	0.0018	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vinorelbine—breast cancer	0.000759	0.0018	CcSEcCtD
Bendroflumethiazide—Nausea—Melphalan—breast cancer	0.000754	0.00179	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Docetaxel—breast cancer	0.000745	0.00177	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Methotrexate—breast cancer	0.000738	0.00175	CcSEcCtD
Bendroflumethiazide—Nausea—Goserelin—breast cancer	0.000736	0.00175	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Epirubicin—breast cancer	0.000735	0.00174	CcSEcCtD
Bendroflumethiazide—Dizziness—Vinorelbine—breast cancer	0.000734	0.00174	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—breast cancer	0.000733	0.00174	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—breast cancer	0.000731	0.00173	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Paclitaxel—breast cancer	0.000731	0.00173	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Thiotepa—breast cancer	0.000725	0.00172	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Capecitabine—breast cancer	0.000721	0.00171	CcSEcCtD
Bendroflumethiazide—Anorexia—Paclitaxel—breast cancer	0.000711	0.00169	CcSEcCtD
Bendroflumethiazide—Vomiting—Vinorelbine—breast cancer	0.000705	0.00167	CcSEcCtD
Bendroflumethiazide—Dizziness—Thiotepa—breast cancer	0.000701	0.00166	CcSEcCtD
Bendroflumethiazide—Rash—Vinorelbine—breast cancer	0.000699	0.00166	CcSEcCtD
Bendroflumethiazide—Dermatitis—Vinorelbine—breast cancer	0.000699	0.00166	CcSEcCtD
Bendroflumethiazide—Hypotension—Paclitaxel—breast cancer	0.000697	0.00165	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—breast cancer	0.000681	0.00161	CcSEcCtD
Bendroflumethiazide—Vomiting—Thiotepa—breast cancer	0.000674	0.0016	CcSEcCtD
Bendroflumethiazide—Rash—Thiotepa—breast cancer	0.000668	0.00158	CcSEcCtD
Bendroflumethiazide—Dermatitis—Thiotepa—breast cancer	0.000667	0.00158	CcSEcCtD
Bendroflumethiazide—Nausea—Vinorelbine—breast cancer	0.000659	0.00156	CcSEcCtD
Bendroflumethiazide—Asthenia—Irinotecan—breast cancer	0.000656	0.00156	CcSEcCtD
Bendroflumethiazide—Asthenia—Mitoxantrone—breast cancer	0.000656	0.00156	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Paclitaxel—breast cancer	0.000649	0.00154	CcSEcCtD
Bendroflumethiazide—Asthenia—Gemcitabine—breast cancer	0.000639	0.00152	CcSEcCtD
Bendroflumethiazide—Constipation—Paclitaxel—breast cancer	0.000638	0.00151	CcSEcCtD
Bendroflumethiazide—Nausea—Thiotepa—breast cancer	0.000629	0.00149	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Mitoxantrone—breast cancer	0.000626	0.00148	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Irinotecan—breast cancer	0.000626	0.00148	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Docetaxel—breast cancer	0.000619	0.00147	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Gemcitabine—breast cancer	0.00061	0.00145	CcSEcCtD
Bendroflumethiazide—Dizziness—Irinotecan—breast cancer	0.000605	0.00144	CcSEcCtD
Bendroflumethiazide—Anorexia—Docetaxel—breast cancer	0.000603	0.00143	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Fluorouracil—breast cancer	0.0006	0.00142	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Capecitabine—breast cancer	0.0006	0.00142	CcSEcCtD
Bendroflumethiazide—Hypotension—Docetaxel—breast cancer	0.000591	0.0014	CcSEcCtD
Bendroflumethiazide—Anorexia—Capecitabine—breast cancer	0.000584	0.00138	CcSEcCtD
Bendroflumethiazide—Vomiting—Irinotecan—breast cancer	0.000582	0.00138	CcSEcCtD
Bendroflumethiazide—Vomiting—Mitoxantrone—breast cancer	0.000582	0.00138	CcSEcCtD
Bendroflumethiazide—Dizziness—Fluorouracil—breast cancer	0.000579	0.00137	CcSEcCtD
Bendroflumethiazide—Rash—Irinotecan—breast cancer	0.000577	0.00137	CcSEcCtD
Bendroflumethiazide—Rash—Mitoxantrone—breast cancer	0.000577	0.00137	CcSEcCtD
Bendroflumethiazide—Dermatitis—Mitoxantrone—breast cancer	0.000576	0.00137	CcSEcCtD
Bendroflumethiazide—Dermatitis—Irinotecan—breast cancer	0.000576	0.00137	CcSEcCtD
Bendroflumethiazide—Hypotension—Capecitabine—breast cancer	0.000572	0.00136	CcSEcCtD
Bendroflumethiazide—Vomiting—Gemcitabine—breast cancer	0.000567	0.00134	CcSEcCtD
Bendroflumethiazide—Rash—Gemcitabine—breast cancer	0.000562	0.00133	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gemcitabine—breast cancer	0.000561	0.00133	CcSEcCtD
Bendroflumethiazide—Vomiting—Fluorouracil—breast cancer	0.000557	0.00132	CcSEcCtD
Bendroflumethiazide—Rash—Fluorouracil—breast cancer	0.000553	0.00131	CcSEcCtD
Bendroflumethiazide—Dermatitis—Fluorouracil—breast cancer	0.000552	0.00131	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Docetaxel—breast cancer	0.00055	0.0013	CcSEcCtD
Bendroflumethiazide—Nausea—Irinotecan—breast cancer	0.000543	0.00129	CcSEcCtD
Bendroflumethiazide—Nausea—Mitoxantrone—breast cancer	0.000543	0.00129	CcSEcCtD
Bendroflumethiazide—Constipation—Docetaxel—breast cancer	0.000541	0.00128	CcSEcCtD
Bendroflumethiazide—Asthenia—Paclitaxel—breast cancer	0.000535	0.00127	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Capecitabine—breast cancer	0.000532	0.00126	CcSEcCtD
Bendroflumethiazide—Nausea—Gemcitabine—breast cancer	0.000529	0.00126	CcSEcCtD
Bendroflumethiazide—Constipation—Capecitabine—breast cancer	0.000524	0.00124	CcSEcCtD
Bendroflumethiazide—Nausea—Fluorouracil—breast cancer	0.00052	0.00123	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Paclitaxel—breast cancer	0.000511	0.00121	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Epirubicin—breast cancer	0.000503	0.00119	CcSEcCtD
Bendroflumethiazide—Dizziness—Paclitaxel—breast cancer	0.000493	0.00117	CcSEcCtD
Bendroflumethiazide—Vomiting—Paclitaxel—breast cancer	0.000474	0.00113	CcSEcCtD
Bendroflumethiazide—Rash—Paclitaxel—breast cancer	0.00047	0.00112	CcSEcCtD
Bendroflumethiazide—Dermatitis—Paclitaxel—breast cancer	0.00047	0.00111	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Doxorubicin—breast cancer	0.000465	0.0011	CcSEcCtD
Bendroflumethiazide—Asthenia—Docetaxel—breast cancer	0.000454	0.00108	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Methotrexate—breast cancer	0.000446	0.00106	CcSEcCtD
Bendroflumethiazide—Nausea—Paclitaxel—breast cancer	0.000443	0.00105	CcSEcCtD
Bendroflumethiazide—Asthenia—Capecitabine—breast cancer	0.000439	0.00104	CcSEcCtD
Bendroflumethiazide—Anorexia—Methotrexate—breast cancer	0.000435	0.00103	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Docetaxel—breast cancer	0.000433	0.00103	CcSEcCtD
Bendroflumethiazide—Hypotension—Methotrexate—breast cancer	0.000426	0.00101	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Capecitabine—breast cancer	0.000419	0.000994	CcSEcCtD
Bendroflumethiazide—Dizziness—Docetaxel—breast cancer	0.000418	0.000992	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—breast cancer	0.000418	0.000991	CcSEcCtD
Bendroflumethiazide—Anorexia—Epirubicin—breast cancer	0.000407	0.000965	CcSEcCtD
Bendroflumethiazide—Dizziness—Capecitabine—breast cancer	0.000405	0.00096	CcSEcCtD
Bendroflumethiazide—Vomiting—Docetaxel—breast cancer	0.000402	0.000954	CcSEcCtD
Bendroflumethiazide—Rash—Docetaxel—breast cancer	0.000399	0.000946	CcSEcCtD
Bendroflumethiazide—Hypotension—Epirubicin—breast cancer	0.000399	0.000946	CcSEcCtD
Bendroflumethiazide—Dermatitis—Docetaxel—breast cancer	0.000398	0.000945	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Methotrexate—breast cancer	0.000396	0.00094	CcSEcCtD
Bendroflumethiazide—Vomiting—Capecitabine—breast cancer	0.000389	0.000924	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—breast cancer	0.000386	0.000917	CcSEcCtD
Bendroflumethiazide—Rash—Capecitabine—breast cancer	0.000386	0.000916	CcSEcCtD
Bendroflumethiazide—Dermatitis—Capecitabine—breast cancer	0.000386	0.000915	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—breast cancer	0.000376	0.000892	CcSEcCtD
Bendroflumethiazide—Nausea—Docetaxel—breast cancer	0.000376	0.000891	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Epirubicin—breast cancer	0.000371	0.00088	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—breast cancer	0.000369	0.000875	CcSEcCtD
Bendroflumethiazide—Constipation—Epirubicin—breast cancer	0.000365	0.000865	CcSEcCtD
Bendroflumethiazide—Nausea—Capecitabine—breast cancer	0.000364	0.000863	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Doxorubicin—breast cancer	0.000343	0.000814	CcSEcCtD
Bendroflumethiazide—Constipation—Doxorubicin—breast cancer	0.000338	0.000801	CcSEcCtD
Bendroflumethiazide—Asthenia—Methotrexate—breast cancer	0.000327	0.000776	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Methotrexate—breast cancer	0.000312	0.00074	CcSEcCtD
Bendroflumethiazide—Asthenia—Epirubicin—breast cancer	0.000306	0.000726	CcSEcCtD
Bendroflumethiazide—Dizziness—Methotrexate—breast cancer	0.000301	0.000715	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Epirubicin—breast cancer	0.000292	0.000692	CcSEcCtD
Bendroflumethiazide—Vomiting—Methotrexate—breast cancer	0.00029	0.000687	CcSEcCtD
Bendroflumethiazide—Rash—Methotrexate—breast cancer	0.000287	0.000682	CcSEcCtD
Bendroflumethiazide—Dermatitis—Methotrexate—breast cancer	0.000287	0.000681	CcSEcCtD
Bendroflumethiazide—Asthenia—Doxorubicin—breast cancer	0.000283	0.000672	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—breast cancer	0.000282	0.000669	CcSEcCtD
Bendroflumethiazide—Vomiting—Epirubicin—breast cancer	0.000271	0.000643	CcSEcCtD
Bendroflumethiazide—Nausea—Methotrexate—breast cancer	0.000271	0.000642	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—breast cancer	0.00027	0.000641	CcSEcCtD
Bendroflumethiazide—Rash—Epirubicin—breast cancer	0.000269	0.000638	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—breast cancer	0.000269	0.000637	CcSEcCtD
Bendroflumethiazide—Dizziness—Doxorubicin—breast cancer	0.000261	0.000619	CcSEcCtD
Bendroflumethiazide—Nausea—Epirubicin—breast cancer	0.000253	0.000601	CcSEcCtD
Bendroflumethiazide—Vomiting—Doxorubicin—breast cancer	0.000251	0.000595	CcSEcCtD
Bendroflumethiazide—Rash—Doxorubicin—breast cancer	0.000249	0.00059	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—breast cancer	0.000249	0.00059	CcSEcCtD
Bendroflumethiazide—Nausea—Doxorubicin—breast cancer	0.000234	0.000556	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—ABCC1—breast cancer	0.000196	0.00048	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA4—breast cancer	0.000195	0.000478	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CA9—breast cancer	0.000195	0.000478	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTT1—breast cancer	0.000194	0.000476	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ACHE—breast cancer	0.000194	0.000476	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA2—breast cancer	0.00019	0.000466	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX2—breast cancer	0.00019	0.000466	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARGC1B—breast cancer	0.00019	0.000465	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FN1—breast cancer	0.000188	0.000461	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SULT1A1—breast cancer	0.000188	0.00046	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX4—breast cancer	0.000188	0.00046	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA4—breast cancer	0.000187	0.000458	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CA9—breast cancer	0.000187	0.000458	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS2—breast cancer	0.000186	0.000456	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP17A1—breast cancer	0.000184	0.000451	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—IDH1—breast cancer	0.000183	0.000449	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA1—breast cancer	0.000183	0.000449	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX2—breast cancer	0.000182	0.000446	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA2—breast cancer	0.000182	0.000446	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ENO1—breast cancer	0.000182	0.000446	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS1—breast cancer	0.000182	0.000446	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NAT2—breast cancer	0.000181	0.000444	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CG—breast cancer	0.00018	0.000441	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX4—breast cancer	0.00018	0.000441	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SULT1A1—breast cancer	0.00018	0.000441	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA4—breast cancer	0.000179	0.000439	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CA9—breast cancer	0.000179	0.000439	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2D6—breast cancer	0.000179	0.000438	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EGF—breast cancer	0.000178	0.000436	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—IDH1—breast cancer	0.000176	0.000431	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA1—breast cancer	0.000176	0.000431	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOA2—breast cancer	0.000175	0.00043	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA2—breast cancer	0.000175	0.000428	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX2—breast cancer	0.000175	0.000428	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NAT2—breast cancer	0.000174	0.000426	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX4—breast cancer	0.000173	0.000423	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SULT1A1—breast cancer	0.000173	0.000423	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—breast cancer	0.00017	0.000418	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—FASN—breast cancer	0.00017	0.000417	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—BCHE—breast cancer	0.000169	0.000415	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA1—breast cancer	0.000169	0.000413	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—IDH1—breast cancer	0.000169	0.000413	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC5A5—breast cancer	0.000167	0.00041	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NAT2—breast cancer	0.000167	0.000408	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF1—breast cancer	0.000165	0.000404	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT2—breast cancer	0.000165	0.000404	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NQO1—breast cancer	0.000162	0.000396	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC2A1—breast cancer	0.000162	0.000396	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—DPYD—breast cancer	0.000159	0.00039	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MED12—breast cancer	0.000159	0.00039	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CD—breast cancer	0.000158	0.000388	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP3A4—breast cancer	0.000158	0.000386	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SERPINE1—breast cancer	0.000157	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALDOA—breast cancer	0.000156	0.000383	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—breast cancer	0.000156	0.000383	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—breast cancer	0.000156	0.000382	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1B1—breast cancer	0.000155	0.00038	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—DPYD—breast cancer	0.000152	0.000373	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MED12—breast cancer	0.000152	0.000373	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HSP90AA1—breast cancer	0.000152	0.000372	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA3—breast cancer	0.000152	0.000372	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC2A2—breast cancer	0.000151	0.00037	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALDOA—breast cancer	0.00015	0.000368	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS3—breast cancer	0.00015	0.000366	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTR—breast cancer	0.000148	0.000362	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCG2—breast cancer	0.000148	0.000362	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CPT1A—breast cancer	0.000148	0.000362	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOA1—breast cancer	0.000148	0.000362	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—DPYD—breast cancer	0.000146	0.000358	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MED12—breast cancer	0.000146	0.000358	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA3—breast cancer	0.000146	0.000357	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—STK11—breast cancer	0.000146	0.000357	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP19A1—breast cancer	0.000146	0.000357	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HPGDS—breast cancer	0.000145	0.000355	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC2A2—breast cancer	0.000145	0.000354	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HBA1—breast cancer	0.000144	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALDOA—breast cancer	0.000144	0.000352	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—breast cancer	0.000143	0.00035	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CPT1A—breast cancer	0.000142	0.000347	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTR—breast cancer	0.000142	0.000347	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCG2—breast cancer	0.000142	0.000347	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RAF1—breast cancer	0.000141	0.000346	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTT1—breast cancer	0.000141	0.000344	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ACHE—breast cancer	0.000141	0.000344	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA3—breast cancer	0.00014	0.000342	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HPGDS—breast cancer	0.000139	0.00034	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC2A2—breast cancer	0.000139	0.00034	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HBA1—breast cancer	0.000138	0.000338	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CB—breast cancer	0.000138	0.000338	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CPT1A—breast cancer	0.000136	0.000333	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTR—breast cancer	0.000136	0.000333	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCG2—breast cancer	0.000136	0.000333	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—COMT—breast cancer	0.000135	0.000332	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTT1—breast cancer	0.000135	0.00033	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ACHE—breast cancer	0.000135	0.00033	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—breast cancer	0.000135	0.00033	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HPGDS—breast cancer	0.000133	0.000326	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP17A1—breast cancer	0.000133	0.000326	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMOX1—breast cancer	0.000133	0.000326	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ITPR1—breast cancer	0.000133	0.000325	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HBA1—breast cancer	0.000132	0.000324	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS1—breast cancer	0.000132	0.000323	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ENO1—breast cancer	0.000132	0.000323	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ACHE—breast cancer	0.000129	0.000317	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTT1—breast cancer	0.000129	0.000317	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2D6—breast cancer	0.000129	0.000317	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—breast cancer	0.000129	0.000316	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP17A1—breast cancer	0.000128	0.000313	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCB1—breast cancer	0.000128	0.000313	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—breast cancer	0.000127	0.000311	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA2—breast cancer	0.000127	0.000311	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ENO1—breast cancer	0.000126	0.000309	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS1—breast cancer	0.000126	0.000309	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HRAS—breast cancer	0.000125	0.000307	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TYMS—breast cancer	0.000125	0.000307	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2D6—breast cancer	0.000124	0.000303	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOR1—breast cancer	0.000124	0.000303	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—breast cancer	0.000124	0.000303	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PLA2G4A—breast cancer	0.000124	0.000303	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—FASN—breast cancer	0.000123	0.000301	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—BCHE—breast cancer	0.000122	0.0003	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP17A1—breast cancer	0.000122	0.0003	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA2—breast cancer	0.000122	0.000298	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS1—breast cancer	0.000121	0.000297	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ENO1—breast cancer	0.000121	0.000297	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC5A5—breast cancer	0.000121	0.000296	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2D6—breast cancer	0.000119	0.000291	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPX1—breast cancer	0.000119	0.000291	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—FASN—breast cancer	0.000118	0.000289	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—BCHE—breast cancer	0.000117	0.000288	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1A1—breast cancer	0.000117	0.000288	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC2A1—breast cancer	0.000117	0.000286	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NQO1—breast cancer	0.000117	0.000286	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA2—breast cancer	0.000117	0.000286	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ERCC2—breast cancer	0.000116	0.000285	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC5A5—breast cancer	0.000116	0.000284	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP3A4—breast cancer	0.000114	0.000279	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—FASN—breast cancer	0.000113	0.000277	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—BCHE—breast cancer	0.000113	0.000276	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NQO1—breast cancer	0.000112	0.000274	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC2A1—breast cancer	0.000112	0.000274	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1B1—breast cancer	0.000112	0.000274	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC5A5—breast cancer	0.000111	0.000272	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—breast cancer	0.000111	0.000271	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSP90AA1—breast cancer	0.00011	0.000269	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—breast cancer	0.000109	0.000268	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP3A4—breast cancer	0.000109	0.000268	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—breast cancer	0.000108	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1B1—breast cancer	0.000107	0.000263	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC2A1—breast cancer	0.000107	0.000263	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NQO1—breast cancer	0.000107	0.000263	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA1—breast cancer	0.000107	0.000262	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSP90AA1—breast cancer	0.000105	0.000258	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP19A1—breast cancer	0.000105	0.000258	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—STK11—breast cancer	0.000105	0.000258	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP3A4—breast cancer	0.000105	0.000257	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1B1—breast cancer	0.000103	0.000252	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA1—breast cancer	0.000102	0.000251	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK3—breast cancer	0.000102	0.00025	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSP90AA1—breast cancer	0.000101	0.000247	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP19A1—breast cancer	0.000101	0.000247	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—STK11—breast cancer	0.000101	0.000247	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CAV1—breast cancer	0.000101	0.000247	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TGFB1—breast cancer	9.89e-05	0.000242	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA1—breast cancer	9.82e-05	0.000241	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—COMT—breast cancer	9.79e-05	0.00024	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—breast cancer	9.74e-05	0.000239	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—STK11—breast cancer	9.68e-05	0.000237	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP19A1—breast cancer	9.68e-05	0.000237	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HMOX1—breast cancer	9.61e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ITPR1—breast cancer	9.59e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—COMT—breast cancer	9.39e-05	0.00023	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—breast cancer	9.34e-05	0.000229	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCB1—breast cancer	9.22e-05	0.000226	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMOX1—breast cancer	9.21e-05	0.000226	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CG—breast cancer	9.2e-05	0.000225	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ITPR1—breast cancer	9.19e-05	0.000225	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—breast cancer	9.16e-05	0.000224	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TYMS—breast cancer	9.06e-05	0.000222	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—COMT—breast cancer	9e-05	0.00022	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—breast cancer	8.96e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PLA2G4A—breast cancer	8.95e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—breast cancer	8.95e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOR1—breast cancer	8.95e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCB1—breast cancer	8.84e-05	0.000217	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMOX1—breast cancer	8.83e-05	0.000216	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ITPR1—breast cancer	8.81e-05	0.000216	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TYMS—breast cancer	8.68e-05	0.000213	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—breast cancer	8.58e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOR1—breast cancer	8.58e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PLA2G4A—breast cancer	8.58e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX1—breast cancer	8.57e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1A1—breast cancer	8.49e-05	0.000208	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCB1—breast cancer	8.48e-05	0.000208	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ERCC2—breast cancer	8.42e-05	0.000206	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CA—breast cancer	8.42e-05	0.000206	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TYMS—breast cancer	8.33e-05	0.000204	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOR1—breast cancer	8.23e-05	0.000202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—breast cancer	8.23e-05	0.000202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PLA2G4A—breast cancer	8.23e-05	0.000202	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX1—breast cancer	8.22e-05	0.000201	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—breast cancer	8.14e-05	0.0002	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1A1—breast cancer	8.14e-05	0.000199	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CD—breast cancer	8.08e-05	0.000198	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ERCC2—breast cancer	8.07e-05	0.000198	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—breast cancer	7.98e-05	0.000196	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—breast cancer	7.91e-05	0.000194	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX1—breast cancer	7.88e-05	0.000193	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1A1—breast cancer	7.8e-05	0.000191	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HRAS—breast cancer	7.79e-05	0.000191	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ERCC2—breast cancer	7.74e-05	0.00019	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NOS3—breast cancer	7.63e-05	0.000187	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—breast cancer	7.59e-05	0.000186	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CAV1—breast cancer	7.3e-05	0.000179	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—breast cancer	7.27e-05	0.000178	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CB—breast cancer	7.05e-05	0.000173	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CAV1—breast cancer	7e-05	0.000171	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—breast cancer	6.98e-05	0.000171	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—breast cancer	6.88e-05	0.000168	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CAV1—breast cancer	6.71e-05	0.000164	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CG—breast cancer	6.65e-05	0.000163	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CG—breast cancer	6.37e-05	0.000156	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CG—breast cancer	6.11e-05	0.00015	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTEN—breast cancer	6.09e-05	0.000149	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CD—breast cancer	5.84e-05	0.000143	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—breast cancer	5.77e-05	0.000141	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CD—breast cancer	5.6e-05	0.000137	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—breast cancer	5.53e-05	0.000136	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NOS3—breast cancer	5.52e-05	0.000135	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CD—breast cancer	5.37e-05	0.000132	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—breast cancer	5.3e-05	0.00013	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NOS3—breast cancer	5.29e-05	0.00013	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CB—breast cancer	5.09e-05	0.000125	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NOS3—breast cancer	5.07e-05	0.000124	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—breast cancer	5.05e-05	0.000124	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CB—breast cancer	4.88e-05	0.00012	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—breast cancer	4.84e-05	0.000119	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CB—breast cancer	4.68e-05	0.000115	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—breast cancer	4.64e-05	0.000114	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTEN—breast cancer	4.4e-05	0.000108	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CA—breast cancer	4.3e-05	0.000105	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTEN—breast cancer	4.22e-05	0.000103	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTEN—breast cancer	4.05e-05	9.91e-05	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—breast cancer	3.51e-05	8.6e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CA—breast cancer	3.11e-05	7.61e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CA—breast cancer	2.98e-05	7.3e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CA—breast cancer	2.85e-05	6.99e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—breast cancer	2.54e-05	6.22e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—breast cancer	2.43e-05	5.96e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—breast cancer	2.33e-05	5.71e-05	CbGpPWpGaD
